UnknownPhase 4

Individualized Homeopathy to Reduce the Use of Antibiotics in Women With Recurrent Uncomplicated Urinary Tract Infections

Germany220 participantsStarted 2023-03-15

Plain-language summary

The aim of the study is to determine the efficacy of individualised homeopathic drug treatment (potency C200 and C1000) compared to placebo in females (age 18\<65) with recurrent urinary tract infections, per definition ≥ 2 UTI in 6 months and/ or ≥ 3 UTI in 9 months.

Who can participate

Age range18 Years – 64 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Females, age 18 \< 64 years
✓. Signed informed consent
✓. Documented recurrent UTI (i.e. ≥ 2 UTI in 6 months and/ or ≥ 3 UTI in 12 months)
✓. No change of other prophylactic treatment (e.g. Urovaxom, oestrogen) for recurrent UTI for at least three months before baseline
✓. No product or dosage change of systemic hormonal treatment (including oral anticonception) for at least three months before baseline
✓. Female participants who are not capable of bearing children or who use a method of contraception that is medically approved by the health authority of the respective country.

What they're measuring

ICIQ-FLUTS:

Timeframe: Baseline to month 9

Trial details

NCT IDNCT05545514

SponsorTechnical University of Munich

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-30

View on ClinicalTrials.gov More Urinary Tract Infection Chronic trials